artesunic acid has been researched along with Brain Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, T; Du, Q; Hanif, S; Ismail, M; Li, Y; Muhammad, P; Shi, B; Yang, W; Zhang, D; Zheng, M | 1 |
| Chen, T; Chen, Z; Liu, L; Liu, Y; Nie, Y; Ouyang, Q; Wei, S; Yin, W; Zeng, F | 1 |
| Efferth, T; Giordano, FA; Krishna, S; Schmiedek, P; Schöttler, U; Wenz, F | 1 |
| Halatsch, ME; Karpel-Massler, G; Kast, RE | 1 |
| Bai, Y; Dong, J; Du, Z; Guo, G; Hu, X; Huang, X; Jia, J; Lian, S; Ma, N; Shi, R; Song, B; Wang, M; Yang, B; Zhang, Y | 1 |
| Berte, N; Eich, M; Kaina, B; Kim, E; Lokan, S | 1 |
| Lee, TY; Lu, H; Sheng, R; Zhang, C | 1 |
| Efferth, T; Hehlgans, S; Reichert, S; Reinboldt, V; Rödel, C; Rödel, F | 1 |
8 other study(ies) available for artesunic acid and Brain Neoplasms
| Article | Year |
|---|---|
Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Apolipoproteins E; Artesunate; Brain Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Glioblastoma; Liposomes; Mice; Temozolomide; Xenograft Model Antitumor Assays | 2022 |
Artesunate inhibits the mevalonate pathway and promotes glioma cell senescence.
Topics: Artesunate; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Glioma; Humans; Hydroxymethylglutaryl CoA Reductases; Metabolic Networks and Pathways; Mevalonic Acid; Models, Biological; Protein Binding; Protein Transport; Sterol Regulatory Element Binding Protein 2; Transcription, Genetic; Tumor Suppressor Protein p53 | 2020 |
Answer to the comment of Hai Lu et al. regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report and review of the literature. Arch Toxicol (2016)".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Artemisinins; Artesunate; Auranofin; Brain Neoplasms; Captopril; Celecoxib; Dacarbazine; Disulfiram; Glioblastoma; Humans; Itraconazole; Molecular Targeted Therapy; Morpholines; Neoplasm Recurrence, Local; Pyrazoles; Ritonavir; Sertraline; Signal Transduction; Sulfonamides; Temozolomide; Treatment Outcome | 2014 |
Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Claudin-1; Gene Expression Regulation, Neoplastic; Glioma; Humans; Neoplasm Invasiveness; RNA, Small Interfering; Signal Transduction; Up-Regulation | 2016 |
Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artemisinins; Artesunate; Brain Neoplasms; Cell Death; Cellular Senescence; Dacarbazine; Glioma; Homologous Recombination; Humans; Mice; Mice, Nude; Temozolomide; Xenograft Model Antitumor Assays | 2016 |
Comments regarding "Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature".
Topics: Artemisinins; Artesunate; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Dacarbazine; Glioblastoma; Humans; Temozolomide | 2017 |
A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin.
Topics: Apoptosis; Artemisinins; Artesunate; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; DNA Repair; Dose-Response Relationship, Drug; Down-Regulation; Glioblastoma; Humans; Inhibitor of Apoptosis Proteins; Neoplasm Proteins; Radiation-Sensitizing Agents; Survivin | 2012 |